Teduglutide|CAS 197922-42-2|DC Chemicals

Cas No.:	197922-42-2
Chemical Name:	Teduglutide
Synonyms:	Teduglutide;ALX 0600;Gattex;Glucagon-like peptide II [2-glycine] (human);H-His-Gly-Asp-Gly-Ser-Phe-Ser-Asp-Glu-Met-Asn-Thr-Ile-Leu-Asp-Asn-Leu-Ala-Ala-Arg-Asp-Phe-Ile-Asn-Trp-Leu-Ile-Gln-Thr-Lys-Ile-Thr-Asp-OH
SMILES:	S(C)CC[C@@H](C(N([H])[C@@H](CC(N([H])[H])=O)C(N([H])[C@@H]([C@@H](C)O)C(N([H])[C@H](C(N([H])[C@H](C(N([H])[C@H](C(N([H])[C@@H](CC(N([H])[H])=O)C(N([H])[C@H](C(N([H])[C@@H](C)C(N([H])[C@@H](C)C(N([H])[C@@H](CCCN([H])C(=N[H])N([H])[H])C(N([H])[C@@H](CC(=O)O)C(N([H])[C@@H](CC1C=CC=CC=1)C(N([H])[C@H](C(N([H])[C@@H](CC(N([H])[H])=O)C(N([H])[C@@H](CC1=CN([H])C2=CC=CC=C12)C(N([H])[C@H](C(N([H])[C@H](C(N([H])[C@H](C(N([H])[C@H](C(N([H])[C@H](C(N([H])[C@H](C(N([H])[C@H](C(N([H])[C@H](C(=O)O)CC(=O)O)=O)[C@@H](C)O)=O)[C@@H](C)CC)=O)CCCCN([H])[H])=O)[C@@H](C)O)=O)CCC(N([H])[H])=O)=O)[C@@H](C)CC)=O)CC(C)C)=O)=O)=O)[C@@H](C)CC)=O)=O)=O)=O)=O)=O)CC(C)C)=O)=O)CC(=O)O)=O)CC(C)C)=O)[C@@H](C)CC)=O)=O)=O)N([H])C([C@H](CCC(=O)O)N([H])C([C@H](CC(=O)O)N([H])C([C@H](CO)N([H])C([C@H](CC1C=CC=CC=1)N([H])C([C@H](CO)N([H])C(CN([H])C([C@H](CC(=O)O)N([H])C(CN([H])C([C@H](CC1=CN=CN1[H])N([H])[H])=O)=O)=O)=O)=O)=O)=O)=O)=O
Formula:	C₁₆₄H₂₅₂N₄₄O₅₅S
M.Wt:	3752.08247999998
Purity:	>98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

MSDS

COA

Cat. No.	Product name	Field of application
DC74600	Lotiglipron	Lotiglipron (PF-07081532) is an orally active GLP-1R agonist. It reduces glucose and body weight, and has the potential to be used in Type 2 diabetes mellitus (T2DM) research.
DC70577	LY3502970 (Orforglipron)	LY-3502970 (Orforglipron) is a potent, selective, orally active non-peptide agonist of glucagon-like peptide-1 (GLP-1) receptor.LY3502970 is a partial agonist, biased toward G protein activation over β-arrestin recruitment at the GLP-1R.
DC46189	Teduglutide	Teduglutide (ALX-0600, Gattex, Revestive, TAK 633) is an analogue of human glucagon-like peptide-2 (GLP-2) and binds to the GLP-2 receptors. Teduglutide prolongs the intestinotrophic properties of GLP-2 in animal models.
DC45570	Tirzepatide sodium salt (LY3298176)	Tirzepatide (LY3298176, GIP/GLP-1 RA, TZP) is a dual GIP/GLP-1 receptor agonist. Tirzepatide differentially induces internalization of the GIP and GLP-1 receptors with EC50 values of 18.2 nM and 18.1 nM, respectively.
DC45527	Avexitide	Avexitide (Exendin (9-39)) is a specific and competitive antagonist of glucagon-like peptide-1 (GLP-1) receptor.
DC10278	LGD-6972	LGD-6972 is a selective and orally active glucagon receptor antagonist. LGD-6972 has the potential for type 2 diabetes research.